Bull&Bear | Webull Skyrockets 374% After Reverse Merger, While Alumis Plummets 17% Amid Continued Decline

In the realm of bullish stocks, Webull (BULL) experienced a remarkable surge, increasing by 374.72%. The company completed a reverse merger with SK Growth Opportunities, providing new growth opportunities and market expansion space. This strategic move has attracted notable investors such as Hillhouse Capital and Xiaomi, enhancing the company's influence in the U.S. market. This maneuver not only boosted the company's valuation but also laid a solid foundation for future development.

TMC the Metals (TMC) saw a 45.13% increase, marking a continuous four-day rise, with a total increase of 74.69% over the past four days. This rise was driven by reports indicating that the Trump administration plans to reserve deep-sea metals to counteract China, leading to a surge in metal futures and mining company stocks.

USA Rare Earth (USAR) also witnessed a rise of 41.40% under the influence of the same report about the Trump administration's strategy to stockpile deep-sea metals, pushing up metal futures and mining stocks.

Third Harmonic Bio (THRD) saw its stock price soar by 39.84%, marking a two-day increase with a total rise of 46.69%. The surge followed the company's announcement of a liquidation plan.

Wellgistics (WGRX) rose by 32.53%. Wellgistics Health, Inc. announced an agreement to acquire Peek Healthcare Technologies, Inc., a strategic move to support over 2,500 patients and achieve an annual operating income of $1.5 million.

In contrast, Alumis (ALMS) saw a decrease of 16.82%, marking a three-day continuous drop, with a total decline of 32.96% over the past three days. The stock's decline of over 31% is set to record one of the largest percentage drops in its history.

MicroAlgo (MLGO) dropped by 14.67%, continuing its decline for five consecutive days with a total decrease of 42.16% over the past five days. This was a reaction from the broader tech sector in response to President Trump's announcement of imposing massive tariffs.

Regeneration Cell Technologies (RGC) decreased by 10.03%. News from the FDA about AI potentially replacing animal testing has led to a significant reaction, although experts suggest it is far from being implemented.

Exodus Movement (EXOD) experienced a decline of 10.55%. BTIG initiated coverage of Exodus Movement Inc. with a buy rating and set a target price of $40.

Luminar Technologies (LAZR) saw a decrease of 9.16%, marking a continuous three-day decline with a total drop of 17.22% over the past three days. Goldman Sachs maintained a sell rating on Luminar Technologies and lowered the target price to $2.